Interestingly, IRS1 Gly(972)Arg mutations were observed in 5.8% of the general population and 10.7% of individuals with type 2 diabetes, suggesting a genetic basis for increased CAD in the diabetic population [19]. The gene discussed is IRS1; the disease is type 2 diabetes mellitus.